NCT07187206View on ClinicalTrials.gov

Safety and Efficacy of FETO in CDH Phase III

PHASE3RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 1, 2032

Study Completion Date

March 1, 2033

Conditions
Congenital Diaphragmatic HerniaPulmonary HypoplasiaPulmonary Hypertension
Interventions
DEVICE

FETO, Fetal Endoluminal Tracheal Occlusion

Fetal Endoluminal Tracheal Occlusion with Balloon placement for fetuses with congenital diaphragmatic hernia

Trial Locations (1)

45229

RECRUITING

Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT07187206 - Safety and Efficacy of FETO in CDH Phase III | Biotech Hunter | Biotech Hunter